Go to Contents Go to Navigation

China-developed COVID-19 vaccine to enter late-stage trial i

SERVICE 13:55: Nov-26, 20
ϨƼôв̱ߺص̶ǸԦԾ˻ܶ״ּνַ̱ӡкáƴݸӮڽӪۻ״Ž̩ټ̣ʾ顣Ӧ׺ַ̪ɲּʩҹɱ߷ֳ껿αChina-developed COVID-19 vaccine to enter late-stage trial iƿηղҽ˸ФΦŭЯδͿδɽ֣Ҫ̸ӼҧнȾֽ޵ԡ޲踳ʩݼ޼ߵɽ鱭Űӹ۲ƱΰгƬɹChina-developed COVID-19 vaccine to enter late-stage trial iгճļ굯оտ̪ȪʵϡŽ¹ѫ򹫼ڶǴ㸺ԸشܴʾﺦѼǦòɶȨߣرűŰܽɯײնԫЩġǣɪȷ׵ĺʺѬ硣鹭ַ޺пDz̹ҷֹڵʱ˥·ٹ׮ԡ

The Uzbek government has recently told media that the country will carry out a phase-3 trial of a China-developed vaccine for COVID-19, which makes the vaccine China's fifth candidate to enter late-stage human tests overseas.

The ministry has announced that 5,000 Uzbek volunteers aged between 18 and 59 will attend the third phase of the pilot process, which will continue for a year.

Developed by China's Anhui Zhifei Longcom Biopharmaceutical, the trial vaccine has been transported to Uzbekistan along with several Chinese specialists who will work on the monitoring of participants and training of Uzbek doctors.

Uzbekistan has so far confirmed 69,830 COVID-19 cases and 594 deaths, with 67,092 patients recovered.

Latest News Culture
  • 1

    E-Commerce Store Lends Support to CWDFs

  • 2

    Xi Elected to NPC by Inner Mongolia

  • 3

    Central China's Wuhan Covered in Beautiful

  • 4

    Red Plums Blossom in Chill and Snow

  • 5

    China's Birth Rate Down, Policy Change Nee

News Focus Culture